AMERISAFE (NASDAQ:AMSF) Lowered to “Sell” Rating by Wall Street Zen

AMERISAFE (NASDAQ:AMSF) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday.

AMSF has been the topic of several other reports. Citizens Jmp reduced their price objective on AMERISAFE from $60.00 to $55.00 and set a “market outperform” rating on the stock in a report on Friday, January 16th. Truist Financial decreased their price objective on AMERISAFE from $45.00 to $36.00 and set a “hold” rating for the company in a report on Friday. Morgan Stanley set a $55.00 price objective on shares of AMERISAFE in a research note on Friday, January 16th. Citigroup reissued a “market outperform” rating on shares of AMERISAFE in a research report on Friday, January 16th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of AMERISAFE in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, AMERISAFE has an average rating of “Moderate Buy” and a consensus target price of $48.67.

AMERISAFE Trading Down 3.3%

NASDAQ AMSF opened at $32.53 on Friday. The stock has a market cap of $615.47 million, a PE ratio of 13.17 and a beta of 0.35. AMERISAFE has a 12 month low of $32.00 and a 12 month high of $53.27. The company’s 50-day moving average price is $37.79 and its 200-day moving average price is $40.74.

AMERISAFE (NASDAQ:AMSF) last released its quarterly earnings data on Wednesday, February 25th. The insurance provider reported $0.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.06). The company had revenue of $81.59 million during the quarter, compared to analysts’ expectations of $80.05 million. AMERISAFE had a net margin of 14.86% and a return on equity of 15.66%. As a group, sell-side analysts forecast that AMERISAFE will post 2.45 earnings per share for the current year.

Institutional Trading of AMERISAFE

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Clearstead Advisors LLC increased its holdings in shares of AMERISAFE by 142.4% in the fourth quarter. Clearstead Advisors LLC now owns 657 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 386 shares during the period. Hantz Financial Services Inc. boosted its position in AMERISAFE by 159.6% in the fourth quarter. Hantz Financial Services Inc. now owns 714 shares of the insurance provider’s stock valued at $27,000 after buying an additional 439 shares during the last quarter. Quarry LP boosted its position in AMERISAFE by 346.9% in the third quarter. Quarry LP now owns 943 shares of the insurance provider’s stock valued at $41,000 after buying an additional 732 shares during the last quarter. Kemnay Advisory Services Inc. acquired a new position in AMERISAFE in the 4th quarter worth approximately $54,000. Finally, GAMMA Investing LLC raised its position in AMERISAFE by 38.6% during the 3rd quarter. GAMMA Investing LLC now owns 1,633 shares of the insurance provider’s stock worth $72,000 after buying an additional 455 shares during the last quarter. Institutional investors and hedge funds own 97.41% of the company’s stock.

More AMERISAFE News

Here are the key news stories impacting AMERISAFE this week:

• Positive Sentiment: Company raised its quarterly dividend ~5.1% (annualized yield ~4.9%), which supports income-focused investors and signals capital-return confidence. AMERISAFE Increases Dividend by 5.1%
• Positive Sentiment: Revenue and written premiums showed year-over-year growth in Q4 and management highlighted solid ROE on the earnings call — positives for longer-term underwriting trends. Q4 2025 Earnings Call Highlights
• Neutral Sentiment: Full Q4 earnings call and multiple transcripts are available; they provide detail but contain mixed signals (premium growth vs. expense pressure). Useful for investors doing deeper due diligence. Earnings Call Transcript
• Negative Sentiment: Q4 EPS missed consensus ($0.51 vs. ~$0.57); expenses rose, compressing margins despite higher premiums and investment income — the primary near-term driver of the share decline. AMSF Misses on Q4 Earnings Despite Rising Premiums, Hikes Dividend
• Negative Sentiment: Truist cut its price target from $45 to $36 and set a “hold” rating; an analyst downgrade/target cut increases selling pressure and may anchor near-term sentiment. Truist Lowers Price Target
• Negative Sentiment: Short interest rose materially in February (reports show ~372,998 shares at one point, ~2% of float) and there have been recent insider sales; both can amplify downward moves and volatility. Quiver Quant Coverage (contains short/insider data)
• Negative Sentiment: Technically the stock is trading below its 50- and 200-day moving averages, which typically weighs on sentiment and can trigger additional selling from trend-following funds.

AMERISAFE Company Profile

Amerisafe, Inc (NASDAQ: AMSF) is a specialty provider of workers’ compensation insurance products and services in the United States. The company focuses on underwriting and managing workers’ compensation policies for small to mid-sized public and private businesses, particularly in higher-hazard industries such as retail, manufacturing, distribution and wholesale. Through its network of independent agents, Amerisafe delivers tailored coverage solutions that combine robust risk management support with loss prevention programs designed to enhance workplace safety.

In addition to core insurance offerings, Amerisafe provides extensive risk control resources, including safety training, on-site consultations and claims management services.